Cas no 151772-24-6 (2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde)

2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde is a versatile heterocyclic compound featuring a quinoline core substituted with chloro, methoxy, and formyl functional groups. Its distinct molecular structure makes it a valuable intermediate in organic synthesis, particularly for the preparation of pharmacologically active compounds and agrochemicals. The presence of reactive sites, including the aldehyde group and halogen substituents, allows for selective modifications, enabling its use in cross-coupling reactions, nucleophilic substitutions, and cyclization processes. This compound exhibits stability under standard conditions, facilitating handling and storage. Its utility in medicinal chemistry and material science research underscores its importance as a building block for developing novel derivatives with tailored properties.
2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde structure
151772-24-6 structure
Product Name:2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde
CAS No:151772-24-6
MF:C11H7Cl2NO2
MW:256.084780931473
CID:860271
PubChem ID:11032482
Update Time:2025-06-08

2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde Chemical and Physical Properties

Names and Identifiers

    • 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde
    • (-)-Bis[1-{(1S,2S,5R)-2-i-propyl-5-methylcyclohexyl}indenyl]zirconium(IV)dichloride
    • 2,4-dichloro-6-methoxy-3-Quinolinecarboxaldehyde
    • AKOS000804235
    • DB-063916
    • 2,4-dichloro-6-methoxy-3-quinolinecarbaldehyde
    • G85862
    • SB69541
    • CS-0097590
    • 151772-24-6
    • DTXSID50452691
    • MDL: MFCD11048980
    • Inchi: 1S/C11H7Cl2NO2/c1-16-6-2-3-9-7(4-6)10(12)8(5-15)11(13)14-9/h2-5H,1H3
    • InChI Key: INUHYLAJVYJEND-UHFFFAOYSA-N
    • SMILES: ClC1C(C=O)=C(N=C2C=CC(=CC2=1)OC)Cl

Computed Properties

  • Exact Mass: 254.98551
  • Monoisotopic Mass: 254.9853839g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 16
  • Rotatable Bond Count: 2
  • Complexity: 264
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 3.2
  • Topological Polar Surface Area: 39.2?2

Experimental Properties

  • PSA: 39.19

2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A189004572-1g
2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde
151772-24-6 95%
1g
$513.60 2022-04-02
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
D909499-1g
2,4-dichloro-6-methoxyquinoline-3-carbaldehyde
151772-24-6 ≥95%
1g
6,120.00 2021-05-17
Chemenu
CM144268-1g
2,4-dichloro-6-methoxyquinoline-3-carbaldehyde
151772-24-6 95%
1g
$557 2021-08-05
Chemenu
CM144268-1g
2,4-dichloro-6-methoxyquinoline-3-carbaldehyde
151772-24-6 95%
1g
$522 2023-02-17
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1168230-250mg
2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde
151772-24-6 95+%
250mg
¥1312 2023-04-15
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1168230-1g
2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde
151772-24-6 95+%
1g
¥4716 2023-04-15
Ambeed
A465000-100mg
2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde
151772-24-6 95%
100mg
$119.0 2025-03-05
Ambeed
A465000-250mg
2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde
151772-24-6 95%
250mg
$200.0 2025-03-05
Ambeed
A465000-1g
2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde
151772-24-6 95%
1g
$539.0 2025-03-05

Additional information on 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde

Introduction to 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde (CAS No. 151772-24-6)

2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde, identified by its Chemical Abstracts Service (CAS) number 151772-24-6, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the quinoline class, a family of molecules known for their diverse biological activities and utility in drug development. The structural features of 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde, particularly the presence of chlorine substituents at the 2 and 4 positions and a methoxy group at the 6 position, along with the aldehyde functionality at the 3 position, contribute to its unique chemical properties and reactivity. These characteristics make it a valuable intermediate in synthetic chemistry and a promising scaffold for the development of novel therapeutic agents.

The quinoline scaffold has a long history in medicinal chemistry, with several well-known drugs derived from this core structure. Notably, chloroquinoline derivatives have been extensively studied for their antimicrobial and anti-inflammatory properties. The introduction of electron-withdrawing groups such as chlorine atoms enhances the electrophilicity of the quinoline ring, making it more susceptible to nucleophilic attack. This property is particularly useful in cross-coupling reactions, which are fundamental to modern drug synthesis. The aldehyde group in 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde further expands its synthetic utility, allowing for condensation reactions with various nucleophiles to form more complex molecules.

In recent years, there has been a surge in research focused on developing new antimicrobial agents due to the rise of antibiotic-resistant pathogens. Quinoline derivatives have been revisited as potential candidates due to their ability to interact with bacterial enzymes and disrupt vital metabolic pathways. The structural modifications present in 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde, such as the methoxy group at position 6, can influence its binding affinity and selectivity towards biological targets. This has led to investigations into its derivatives as potential inhibitors of bacterial gyrase and topoisomerase enzymes, which are crucial for DNA replication in bacteria.

Moreover, the compound's aldehyde functionality makes it an attractive precursor for the synthesis of heterocyclic compounds via condensation reactions with primary amines or hydrazines. These reactions yield imines or hydrazones, respectively, which can be further functionalized to produce more complex structures. Such transformations are pivotal in drug discovery pipelines, where diversification of molecular structures is key to identifying novel bioactive entities. The versatility of 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde as a synthetic building block has been leveraged in several research endeavors aimed at developing new therapeutic interventions.

Recent studies have also explored the pharmacokinetic properties of quinoline derivatives to improve their bioavailability and reduce toxicity. The chlorine atoms in 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde can influence metabolic pathways by affecting electron distribution across the molecule. Understanding these interactions is crucial for optimizing drug design and ensuring efficacy while minimizing side effects. Advances in computational chemistry have enabled researchers to model these interactions with high precision, allowing for the rational design of next-generation quinoline-based drugs.

The role of 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde in medicinal chemistry extends beyond antimicrobial applications. Its structural motif is also relevant in the development of anticancer agents. Quinoline derivatives have shown promise as kinase inhibitors due to their ability to disrupt signal transduction pathways involved in cancer cell proliferation. The presence of both electron-withdrawing and electron-donating groups in 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde fine-tunes its binding interactions with target proteins, making it a candidate for structure-based drug design.

In conclusion, 2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde (CAS No. 151772-24-6) represents a versatile and pharmacologically relevant compound that continues to be explored in pharmaceutical research. Its unique structural features offer opportunities for developing novel therapeutic agents across multiple disease areas. As research progresses, further insights into its biological activities and synthetic applications will undoubtedly expand its utility in drug discovery and development.

Recommended suppliers
SHOCHEM(SHANGHAI) CO.,lTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
SHOCHEM(SHANGHAI) CO.,lTD
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Jinan Hanyu Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinan Hanyu Chemical Co.,Ltd.
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hangzhou Cedareal Technology Co., Ltd.